Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
21.7M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6.83M
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$16.6M
-
Value change
-
-$245K
-
Put/Call ratio
-
1.5
-
Number of buys
-
8
-
Number of sells
-
-11
-
Price
-
$2.43
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2023
33 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q1 2023.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.83M shares
of 21.7M outstanding shares and own 31.51% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.39M shares), Stonepine Capital Management, LLC (1.04M shares), WASATCH ADVISORS LP (1M shares), COWEN AND COMPANY, LLC (944K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (503K shares), VANGUARD GROUP INC (491K shares), MORGAN STANLEY (481K shares), PERKINS CAPITAL MANAGEMENT INC (260K shares), Nantahala Capital Management, LLC (133K shares), and UBS Group AG (131K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.